4.7 Article

Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing age

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis

Alberto Calvi et al.

Summary: This study found that slowly expanding lesions (SELs) make up a significant proportion of T2 lesions in secondary progressive multiple sclerosis (SPMS). These lesions are associated with neurodegenerative MRI markers and clinical worsening, suggesting that they may contribute to disease progression and be a new target for therapeutic interventions.

NEUROLOGY (2022)

Review Immunology

The role of T cells in age-related diseases

Elisa Carrasco et al.

Summary: T cells play a crucial role in age-related diseases, potentially leading to the failure of immune tolerance mechanisms and tissue damage. Targeting T cells could offer new therapeutic opportunities to enhance resilience to age-related diseases.

NATURE REVIEWS IMMUNOLOGY (2022)

Review Cell Biology

Thymus involution sets the clock of the aging T-cell landscape: Implications for declined immunity and tissue repair

Yehezqel Elyahu et al.

Summary: Aging is characterized by gradual tissue damage, immune regulation decline, and systemic inflammation. CD4 T cells are crucial for immune orchestration, while thymus involution may severely impact tissue repair.

AGEING RESEARCH REVIEWS (2021)

Review Genetics & Heredity

Telomere Length as a Marker of Biological Age: State-of-the-Art, Open Issues, and Future Perspectives

Alexander Vaiserman et al.

Summary: Telomere length has long been considered one of the best biomarkers of aging, but recent research suggests that it can only provide a rough estimate of aging rate. Other indicators such as immune parameters and epigenetic age may be stronger predictors of health status and risk for chronic diseases.

FRONTIERS IN GENETICS (2021)

Article Multidisciplinary Sciences

Involvement of cytotoxic Eomes-expressing CD4+ T cells in secondary progressive multiple sclerosis

Ben J. E. Raveney et al.

Summary: This study identified a subset of cytotoxic CD4(+) T cells expressing Eomes, known as Eomes(+) Th cells, that are crucially involved in the pathogenesis of secondary progressive MS (SPMS). Eomes levels could act as a biomarker to predict disease worsening in SPMS patients with over 80% accuracy. These findings have significant implications for SPMS biomarkers and potential therapeutic targets.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Clinical Neurology

Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis

Melanie Eschborn et al.

Summary: This study revealed age-related changes in immune cell composition in patients with multiple sclerosis, especially in the CD8 T-cell compartment. The expression of immunoregulatory molecules decreased with age in healthy donors but not in MS patients, while the increase in CD226 expression on memory CD8 T cells with age was absent in MS patients. This suggests a dysregulation of immune signals in MS and premature immune aging in young MS patients, with potential implications for disease severity.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)

Review Immunology

Hallmarks of T cell aging

Maria Mittelbrunn et al.

Summary: In this Review, Mittelbrunn and Kroemer propose ten molecular hallmarks as common denominators of T cell aging, which include primary and secondary hallmarks explaining the manifestation of T cell aging and its impact on overall deterioration. The challenge now is to weigh the relative impact of these hallmarks on T cell aging and understand their interconnections, with the goal of defining molecular targets for interventions in the aging process.

NATURE IMMUNOLOGY (2021)

Review Immunology

Immunosenescence in multiple sclerosis: the identification of new therapeutic targets

Maria Dema et al.

Summary: The number of elderly multiple sclerosis patients is increasing due to improved life expectancy and available treatments. Current treatments cannot halt disability accumulation associated with disease progression, potentially due to the impact of immunosenescence, leading to abnormal immune cell subsets contributing to autoimmune disease development. Strategies including senolytics, regenerative therapies, and rejuvenation of immune cells have been proposed to potentially reverse immunosenescence and benefit MS progression.

AUTOIMMUNITY REVIEWS (2021)

Review Clinical Neurology

Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances

Amit Bar-Or et al.

Summary: The pathogenesis of multiple sclerosis is being redefined by new insights from basic and translational studies, indicating involvement of various cell types and subsets in the inflammatory responses. Imbalanced interactions between T cells, myeloid cells, B cells, and their subpopulations play a crucial role in relapsing multiple sclerosis, with patient-specific contributors to these imbalances. Single-cell immune cell profiling techniques reveal functional heterogeneity and plasticity that could impact disease progression and treatment response. Clinical trials with different agents have helped to elucidate disease mechanisms, clarify immune therapy modes of action, and set the stage for new therapeutic strategies.

LANCET NEUROLOGY (2021)

Review Clinical Neurology

Secondary Progressive Multiple Sclerosis New Insights

Bruce A. C. Cree et al.

Summary: In most cases, multiple sclerosis begins with a relapsing-remitting course followed by secondary progressive MS (SMPS), and there are major differences between RRMS and SPMS in terms of treatment response and diagnosis. However, clear criteria marking the transition from RRMS to SPMS have not been established yet. Early identification of SPMS will require tools that, along with appropriate treatment, may lead to better long-term outcomes.

NEUROLOGY (2021)

Article Cell Biology

Accumulation of cytotoxic T cells in the aged CNS leads to axon degeneration and contributes to cognitive and motor decline

Janos Groh et al.

Summary: Aging is a major risk factor for the development of nervous system functional decline, even in the absence of diseases or trauma. CD8(+) T cells play a role in driving axon degeneration and promoting cognitive and motor decline in the aging CNS, suggesting they may be a potential target for treating age-related decline in brain structure and function.

NATURE AGING (2021)

Article Multidisciplinary Sciences

Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

David Schafflick et al.

NATURE COMMUNICATIONS (2020)

Review Geriatrics & Gerontology

Contributions of Age-Related Thymic Involution to Immunosenescence and Inflammaging

Rachel Thomas et al.

IMMUNITY & AGEING (2020)

Article Clinical Neurology

Exosome-enriched fractions from MS B cells induce oligodendrocyte death

Joyce A. Benjamins et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)

Article Multidisciplinary Sciences

Extrapituitary prolactin promotes generation of Eomes-positive helper T cells mediating neuroinflammation

Chenyang Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Article Multidisciplinary Sciences

Single-cell transcriptomics reveals expansion of cytotoxic CD4 T cells in supercentenarians

Kosuke Hashimoto et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

Review Immunology

Mechanisms underlying T cell ageing

Jorg J. Goronzy et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Clinical Neurology

Identification of Chronic Active Multiple Sclerosis Lesions on 3T MRI

M. Absinta et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2018)

Article Clinical Neurology

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis

Roberta Magliozzi et al.

ANNALS OF NEUROLOGY (2018)

Article Clinical Neurology

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

Alan J. Thompson et al.

LANCET NEUROLOGY (2018)

Review Clinical Neurology

Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients

Elizabeth A. Mills et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Medicine, General & Internal

Multiple Sclerosis

Daniel S. Reich et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Clinical Neurology

Aging and lymphocyte changes by immunomodulatory therapies impact PML risk in multiple sclerosis patients

Elizabeth A. Mills et al.

MULTIPLE SCLEROSIS JOURNAL (2018)

Review Immunology

Immunosenescence and Inflamm-Aging As Two Sides of the Same Coin: Friends or Foes?

Tamas Fulop et al.

FRONTIERS IN IMMUNOLOGY (2018)

Article Immunology

CTLA-4, PD-1 and TIM-3 expression predominantly downregulated in MS patients

Adel Mohammadzadeh et al.

JOURNAL OF NEUROIMMUNOLOGY (2018)

Review Hematology

CTLA-4: a moving target in immunotherapy

Behzad Rowshanravan et al.

Review Immunology

The twilight of immunity: emerging concepts in aging of the immune system

Janko Nikolich-Zugich

NATURE IMMUNOLOGY (2018)

Review Immunology

Successful and Maladaptive T Cell Aging

Jorg J. Goronzy et al.

IMMUNITY (2017)

Article Clinical Neurology

Comorbidity in multiple sclerosis: implications for patient care

Ruth Ann Marrie

NATURE REVIEWS NEUROLOGY (2017)

Article Clinical Neurology

Dimethyl fumarate-induced lymphopenia in MS due to differential T-cell subset apoptosis

Mahtab Ghadiri et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2017)

Article Medicine, Research & Experimental

Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions

Martina Absinta et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Clinical Neurology

Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark

Anja Thormann et al.

JOURNAL OF NEUROLOGY (2016)

Article Multidisciplinary Sciences

Alterations of the human gut microbiome in multiple sclerosis

Sushrut Jangi et al.

NATURE COMMUNICATIONS (2016)

Article Multidisciplinary Sciences

Standardizing Flow Cytometry Immunophenotyping Analysis from the Human ImmunoPhenotyping Consortium

Greg Finak et al.

SCIENTIFIC REPORTS (2016)

Article Cell Biology

Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy

Rui Li et al.

SCIENCE TRANSLATIONAL MEDICINE (2015)

Article Multidisciplinary Sciences

Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation

Ben J. E. Raveney et al.

NATURE COMMUNICATIONS (2015)

Review Immunology

Immunology of Relapse and Remission in Multiple Sclerosis

Lawrence Steinman

ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)

Review Immunology

The who's who of T-cell differentiation: Human memory T-cell subsets

Yolanda D. Mahnke et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2013)

Article Clinical Neurology

T-cell homeostasis in pediatric multiple sclerosis Old cells in young patients

Bettina Balint et al.

NEUROLOGY (2013)

Review Clinical Neurology

Progressive multiple sclerosis: pathology and pathogenesis

Hans Lassmann et al.

NATURE REVIEWS NEUROLOGY (2012)

Article Biotechnology & Applied Microbiology

Infection with cytomegalovirus but not herpes simplex virus induces the accumulation of late-differentiated CD4+ and CD8+ T-cells in humans

Evelyna Derhovanessian et al.

JOURNAL OF GENERAL VIROLOGY (2011)

Review Immunology

T cell exhaustion

E. John Wherry

NATURE IMMUNOLOGY (2011)

Article Immunology

Thymic involution and proliferative T-cell responses in multiple sclerosis

Danielle A. Duszczyszyn et al.

JOURNAL OF NEUROIMMUNOLOGY (2010)

Review Virology

Cytomegalovirus and human immunosenescence

Graham Pawelec et al.

REVIEWS IN MEDICAL VIROLOGY (2009)

Review Immunology

CD28- T cells: their role in the age-associated decline of immune function

Nan-ping Weng et al.

TRENDS IN IMMUNOLOGY (2009)

Article Cell Biology

CTLA-4 upregulation during aging

QB Leng et al.

MECHANISMS OF AGEING AND DEVELOPMENT (2002)